Industry

An antibody that could treat immune system disorders could be on the path to clinical trials after securing $20 million in Series A funding.

Start-up company Scaled Biolabs Inc is changing the way researchers around the world conduct manual cellular experiments and accelerating discoveries in biology by providing novel devices that enable 1000’s of experiments to occur simultaneously.

A new facility for enzyme formulation and production has been opened, strengthening a collaboration between the Australian Institute for Bioengineering and Nanotechnology and industry partner Bioproton.

Leading American biotechnology company Amyris, Inc. and the Australian Institute for Bioengineering and Nanotechnology at The University of Queensland have signed a Memorandum of Understanding to support the development of a Queensland-based biotechnology industry using feedstock from local sugarcane.